NEXT
Sign in to follow

The Legal Intelligencer

FDA Moves Toward a Streamlined Regulatory Process for Artificial Intelligence

A question that investors frequently ask of emerging growth life sciences companies is whether they have considered how to monetize the data they will inevitably collect in the development, marketing and sale of their service or product.
5 minute read

New Jersey Law Journal

Judge Denies Injunction Forcing Arbitration in Johnson & Johnson Shareholder Dispute

A federal judge has rejected a bid for emergent relief by a Johnson & Johnson shareholder asking the company to institute mandatory arbitration of shareholder disputes in lieu of class action litigation.
4 minute read

The Legal Intelligencer

$775M Global Accord Reached in Xarelto Litigation

Nationwide litigation over claims that Bayer and Johnson & Johnson failed to warn about the risks of the blood thinner Xarelto has come to a global settlement of $775 million.
3 minute read

The Legal Intelligencer

Pa. Appeals Court Affirms State's Jurisdiction Over Pelvic Mesh Mass Tort

A three-judge Superior Court panel determined that ties between Ethicon, a J&J subsidiary that is the main defendant in the pelvic mesh litigation in Philadelphia, and Secant, a Pennsylvania-based company that was involved in manufacturing the mesh product at issue, were sufficient to establish jurisdiction in the Keystone State.
3 minute read

The Recorder

Hueston Hennigan Alleges 'Catch and Kill' Pharma Scheme

John Hueston and Steven Feldman claim in a superior court suit that billionaire Patrick Soon-Shiong bought the rights to a promising cancer treatment only to squelch it — and then backed out of the deal.
3 minute read

Law.com

Critical Mass: Class Needs Replacement as Embattled Michael Avenatti Exits. Plus, Fee Battle Roils Mesh Litigation

With Avenatti stepping away from $454 million case on appeal, as he begins to fight criminal charges, court has an array of choices to lead the litigation
5 minute read

New Jersey Law Journal

Johnson & Johnson Litigation Chief to Become Top Lawyer at Stryker

A Johnson & Johnson attorney responsible for litigation has been tapped to he the next chief legal officer of medical technology company Stryker.
3 minute read

National Law Journal

Ex-SEC Commissioner, Top Mylan Lawyer Returns to Wilmer

Daniel Gallagher, currently chief legal officer at drug maker Mylan, served on SEC for four years during the Obama administration.
3 minute read

The Legal Intelligencer

Pharmaceutical Patent Term Extensions and Patent Term Adjustments: Choose Wisely

For pharmaceutical inventions, which usually undergo a lengthy FDA approval process before any drug can be sold, the most valuable portion of patent term is at the end of the patent's life, after FDA approval.
9 minute read

Corporate Counsel

Stryker's Next Chief Legal Officer Currently Leads Litigation at Johnson & Johnson

A Johnson & Johnson attorney responsible for litigation has been tapped to he the next chief legal officer of medical technology company Stryker.
3 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025

    Brought to you by Erase.com

    Download Now

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now